Kamada (KMDA) Revenue (2012 - 2026)
Kamada (KMDA) posted quarterly Revenue of $45.2 million for Q1 2026, up 2.78% year-on-year from $44.0 million in Q1 2025, and up 1.26% on a QoQ basis from $44.7 million in Q4 2025.
Kamada (KMDA) Revenue (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Revenue for 15 consecutive years, with $45.2 million the latest figure, recorded in Q1 2026.
- Quarterly Revenue rose 2.78% year-over-year to $45.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.9 billion (up 5.39% YoY) and the FY2025 annual result came in at $180.5 million, up 12.12% from the prior year.
- Revenue rose to $45.2 million in Q1 2026 per KMDA's latest filing, from $44.7 million in the prior quarter.
- Over the last five years, Revenue for KMDA reached as high as $44.8 billion in Q2 2025 and fell as low as $23.6 million in Q2 2022.
- A 5-year average of $8.9 billion and a median of $44.0 million in 2025 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue soared 139767.15% — and 2023, when it slumped 99.88%.
- Year by year, Revenue stood at $45.4 million in 2022, then declined by 19.82% to $36.4 million in 2023, then advanced by 7.06% to $39.0 million in 2024, then rose by 14.54% to $44.7 million in 2025, then advanced by 1.26% to $45.2 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $45.2 million, $44.7 million, and $47.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 781.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 45.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.24 Mn |
| Dec 31, 2025 | 44.68 Mn |
| Sep 30, 2025 | 47.01 Mn |
| Jun 30, 2025 | 44.75 Bn |
| Mar 31, 2025 | 44.02 Mn |
| Dec 31, 2024 | 39.01 Mn |
| Sep 30, 2024 | 41.74 Mn |
| Jun 30, 2024 | 42.47 Bn |
| Mar 31, 2024 | 37.74 Mn |
| Dec 31, 2023 | 36.43 Mn |
| Sep 30, 2023 | 37.93 Mn |
| Jun 30, 2023 | 37.44 Mn |
| Mar 31, 2023 | 30.71 Bn |
| Dec 31, 2022 | 45.44 Mn |
| Sep 30, 2022 | 32.22 Bn |
| Jun 30, 2022 | 23.59 Mn |
| Mar 31, 2022 | 28.09 Mn |
| Dec 31, 2021 | 31.47 Mn |
| Sep 30, 2021 | 23.03 Mn |
| Jun 30, 2021 | 24.24 Mn |